다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of the American College of Cardiology, v.56 no.9, 2010년, pp.683 - 691
Marsh, J.D. , Keyrouz, S.G.
AI-Helper
The decline in stroke incidence and mortality in the U.S. over the past 20 years is reaching a plateau, and the number of strokes may actually start to increase as the population ages. However, recent clinical trials have demonstrated that there are numerous opportunities to improve stroke preventio...
Circulation Lloyd-Jones 119 e21 2009 Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Stroke Petrea 40 1032 2009 10.1161/STROKEAHA.108.542894 Gender differences in stroke incidence and poststroke disability in the Framingham Heart Study
Circulation White 111 1327 2005 10.1161/01.CIR.0000157736.19739.D0 Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study
Stroke Amarenco 35 2902 2004 10.1161/01.STR.0000147965.52712.fa Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis
Lancet Collins 363 757 2004 10.1016/S0140-6736(04)15690-0 Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions
Drugs Sever 64 43 2004 10.2165/00003495-200464002-00005
Stroke Nassief 39 1042 2008 10.1161/STROKEAHA.107.501361 Statin therapy for stroke prevention
Lancet Colhoun 364 685 2004 10.1016/S0140-6736(04)16895-5 Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
Stroke Adams 39 1647 2008 10.1161/STROKEAHA.107.189063 Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack
N Engl J Med 358 2545 2008 10.1056/NEJMoa0802743 Effects of intensive glucose lowering in type 2 diabetes
Stroke Amarenco 40 1405 2009 10.1161/STROKEAHA.108.534107 Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes
N Engl J Med Taylor 361 1 2009 10.1056/NEJMoa0907569 Extended-release niacin or ezetimibe and carotid intima-media thickness
Neurology Chaturvedi 65 794 2005 10.1212/01.wnl.0000176036.07558.82 Carotid endarterectomy-an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
JAMA 273 1421 1995 10.1001/jama.1995.03520420037035 Endarterectomy for asymptomatic carotid artery stenosis
Stroke Goldstein 37 1583 2006 10.1161/01.STR.0000223048.70103.F1
N Engl J Med Yadav 351 1493 2004 10.1056/NEJMoa040127 Protected carotid-artery stenting versus endarterectomy in high-risk patients
N Engl J Med Mas 355 1660 2006 10.1056/NEJMoa061752 Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis
Lancet Ringleb 368 1239 2006 10.1016/S0140-6736(06)69122-8 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial
Lancet Neurol Stingele 7 216 2008 10.1016/S1474-4422(08)70024-3 Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study
Stroke Howard 40 1140 2009 10.1161/STROKEAHA.108.541847 Does sex matter?
Circulation 84 527 1991 10.1161/01.CIR.84.2.527 Stroke Prevention in Atrial Fibrillation study: final results
Lancet 343 687 1994 Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study
JAMA Gage 285 2864 2001 10.1001/jama.285.22.2864 Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation
J Am Coll Cardiol Fuster 48 854 2006 10.1016/j.jacc.2006.07.009
N Engl J Med Connolly 361 1139 2009 10.1056/NEJMoa0905561 Dabigatran versus warfarin in patients with atrial fibrillation
N Engl J Med 360 2066 2009 10.1056/NEJMoa0901301 Effect of clopidogrel added to aspirin in patients with atrial fibrillation
Lancet 367 1903 2006 10.1016/S0140-6736(06)68845-4 Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial
Circulation Massie 119 1616 2009 10.1161/CIRCULATIONAHA.108.801753 Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial
J Card Fail Pullicino 12 39 2006 10.1016/j.cardfail.2005.07.007 Warfarin Versus Aspirin in Patients With Reduced Cardiac Ejection Fraction (WARCEF): rationale, objectives, and design
N Engl J Med Amarenco 331 1474 1994 10.1056/NEJM199412013312202 Atherosclerotic disease of the aortic arch and the risk of ischemic stroke
Stroke Russo 40 2313 2009 10.1161/STROKEAHA.109.548313 Atherosclerotic disease of the proximal aorta and the risk of vascular events in a population-based cohort: the Aortic Plaques and Risk of Ischemic Stroke (APRIS) study
Circulation Homma 112 1063 2005 10.1161/CIRCULATIONAHA.104.524371 Patent foramen ovale and stroke
N Engl J Med Handke 357 2262 2007 10.1056/NEJMoa071422 Patent foramen ovale and cryptogenic stroke in older patients
J Am Coll Cardiol O'Gara 53 2014 2009 10.1016/j.jacc.2009.04.001 Percutaneous device closure of patent foramen ovale for secondary stroke prevention
Lancet Wohrle 368 350 2006 10.1016/S0140-6736(06)69087-9 Closure of patent foramen ovale after cryptogenic stroke
Circulation Homma 105 2625 2002 10.1161/01.CIR.0000017498.88393.44 Effect of medical treatment in stroke patients with patent foramen ovale: Patent Foramen Ovale in Cryptogenic Stroke Study
Lancet Neal 356 1955 2000 10.1016/S0140-6736(00)03307-9 Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials
JAMA 288 2981 2002 10.1001/jama.288.23.2981 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Stroke Rosamond 30 736 1999 10.1161/01.STR.30.4.736 Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort
Neurology Longstreth 56 368 2001 10.1212/WNL.56.3.368 Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study
Stroke Sturgeon 38 2718 2007 10.1161/STROKEAHA.107.487090 Risk factors for intracerebral hemorrhage in a pooled prospective study
Stroke Kurth 34 1151 2003 10.1161/01.STR.0000065200.93070.32 Smoking and the risk of hemorrhagic stroke in men
Stroke Kurth 34 2792 2003 10.1161/01.STR.0000100165.36466.95 Smoking and risk of hemorrhagic stroke in women
Circulation Chiuve 118 947 2008 10.1161/CIRCULATIONAHA.108.781062 Primary prevention of stroke by healthy lifestyle
Neurology Marler 55 1649 2000 10.1212/WNL.55.11.1649 Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study
Stroke Demaerschalk 36 2500 2005 10.1161/01.STR.0000185699.37843.14 Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States
N Engl J Med Hacke 359 1317 2008 10.1056/NEJMoa0804656 Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Stroke del Zoppo 40 2945 2009 10.1161/STROKEAHA.109.192535 Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator
N Engl J Med Alexandrov 351 2170 2004 10.1056/NEJMoa041175 Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke
Stroke del Zoppo 29 4 1998 10.1161/01.STR.29.1.4 PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke
JAMA Furlan 282 2003 1999 10.1001/jama.282.21.2003 Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial
Stroke 35 904 2004 10.1161/01.STR.0000121641.77121.98 Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke study
Stroke 38 2127 2007 10.1161/STROKEAHA.107.483131 The Interventional Management of Stroke (IMS) II study
Stroke Smith 36 1432 2005 10.1161/01.STR.0000171066.25248.1d Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial
Stroke Smith 39 1205 2008 10.1161/STROKEAHA.107.497115 Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial
Stroke Broderick 38 2001 2007 10.1161/STROKEAHA.107.183689
Stroke Broderick 24 987 1993 10.1161/01.STR.24.7.987 Volume of intracerebral hemorrhage
Neurology Davis 66 1175 2006 10.1212/01.wnl.0000208408.98482.99 Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage
Crit Care Med Tuhrim 27 617 1999 10.1097/00003246-199903000-00045 Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage
Stroke Hua 38 759 2007 10.1161/01.STR.0000247868.97078.10 Brain injury after intracerebral hemorrhage: the role of thrombin and iron
Stroke Daverat 22 1 1991 10.1161/01.STR.22.1.1 Death and functional outcome after spontaneous intracerebral hemorrhage
Lancet 358 1033 2001 10.1016/S0140-6736(01)06178-5 Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
J Hypertens Zhang 26 1446 2008 10.1097/HJH.0b013e328300a24a Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China
Neurology Powers 57 18 2001 10.1212/WNL.57.1.18 Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage
J Cereb Blood Flow Metab Zazulia 21 804 2001 10.1097/00004647-200107000-00005 Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage
Lancet Neurol Anderson 7 391 2008 10.1016/S1474-4422(08)70069-3 Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT): a randomised pilot trial
Stroke Kazui 27 1783 1996 10.1161/01.STR.27.10.1783 Enlargement of spontaneous intracerebral hemorrhage: incidence and time course
Stroke Brott 28 1 1997 10.1161/01.STR.28.1.1 Early hemorrhage growth in patients with intracerebral hemorrhage
Intensive Care Med Mayer 28 Suppl 2 S235 2002 10.1007/s00134-002-1470-8 Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy
Stroke Mayer 36 74 2005 10.1161/01.STR.0000149628.80251.b8 Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage
N Engl J Med Mayer 352 777 2005 10.1056/NEJMoa042991 Recombinant activated factor VII for acute intracerebral hemorrhage
N Engl J Med Mayer 358 2127 2008 10.1056/NEJMoa0707534 Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage
Lancet McKissock 2 221 1961 10.1016/S0140-6736(61)90353-1 Primary intracerebral hemmorrhage: a controlled trial of conservative and surgical treatment in 180 unselected cases
Stroke Fernandes 31 2511 2000 10.1161/01.STR.31.10.2511 Surgery in intracerebral hemorrhage: the uncertainty continues
Cochrane Database Syst Rev Prasad 8 2008 Surgery for primary supratentorial intracerebral haemorrhage
Lancet Mendelow 365 387 2005 10.1016/S0140-6736(05)70233-6 Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial
Stroke Hart 36 1588 2005 10.1161/01.STR.0000170642.39876.f2 Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas
Stroke Cucchiara 39 2993 2008 10.1161/STROKEAHA.108.520668 Hematoma growth in oral anticoagulant related intracerebral hemorrhage
Neurology Flaherty 71 1084 2008 10.1212/01.wnl.0000326895.58992.27 Warfarin use leads to larger intracerebral hematomas
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.